Medical Discovery Teams

submenu

How to apply

  • Email a curriculum vitae, a brief statement of research interests with future plans, and a one-to-two page vision statement for the Discovery Team to Kathleen Beterams at kbeteram@umn.edu.
  • Complete the online application, which found at the University's Employment site by searching under key words. 

Minnesota Neuroscience Medical Discovery Team on Addiction

Background

Substance abuse is the largest preventable cause of death in the United States. The state of Minnesota has appropriated significant funds over the next ten years for the University of Minnesota Medical School to create a world-class neuroscience-based translational program for the study of addiction. Leading the charge to recruit the team leader of this Medical Discovery Team on Addiction are Dean of the Medical School, Dr. Brooks Jackson, and Dr. Timothy Ebner, Head of the Department of Neuroscience.

Team leadership

We are seeking a world-renowned neuroscientist who has the vision to link basic research to new therapeutic approaches. First, the leader will identify and address opportunities for growth through the targeted hires of eight additional faculty. Second, the leader will bring together existing faculty and infrastructure at the University of Minnesota invested in addiction research and patient outcomes. Third, building on the synergy between the new hires and existing strengths, the team leader will promote the research enterprise through aggressive targeting of federal funding mechanisms.

Research infrastructure

Minnesota Neuroscience Medical Discovery Team On AddictionThe team leader will be able to leverage the University of Minnesota’s current research strength in addiction. The National Institute on Drug Abuse (NIDA)-based research funding currently stands at ~$18M per year. Funded research includes studies of psychostimulants, nicotine, and opioids. We have the newly established NorthStar Node of the NIDA Clinical Trials Network, which serves as a national platform for pragmatic clinical effectiveness trials in addiction. There is the recently funded ($7.5M) program to ready a vaccine against opioid addiction for clinical trials. Further, addiction-based research is funded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), the National Cancer Institute (NCI) and the National Heart, Lung, and Blood Institute (NHLBI) at $11.4M per year.

Additional strengths at the University of Minnesota include the internationally-recognized Center for Magnetic Resonance Research - at the forefront of the human connectome project, the Institute for Therapeutics Discovery and Development that provides the resources and expertise for the development of new drug therapies; the Clinical and Translational Science Institute, providing a conduit to promote the community-wide understanding and application of scientific discoveries and the resources to implement new treatment strategies.

Potential partners

Potential partners in the state of Minnesota include multiple biomedical research companies (e.g. Medtronic, Boston Scientific, Upsher-Smith Laboratories) where development of therapeutic approaches to addiction is a priority. Minnesota also is the home for multiple world-renowned hospital and treatment centers for addiction, including the Mayo Clinic, the Minneapolis VA and the Hazelden Betty Ford Foundation.

Application information

Applications should be received by November 13, 2015 and include a curriculum vitae, a brief statement of research interests with future plans, and a one-to-two page vision statement for the Discovery Team.  Electronic versions should be emailed to Kathleen Beterams at kbeteram@umn.edu.  Applicants also need to complete the online application. This may be found at the University's Employment site by searching under key words. Additional questions can be directed to Dr. Timothy Ebner at ebner001@umn.edu.